Scientific Name | Pharmaceutical form | Strength Value |
---|---|---|
Newcastle disease virus LaSota strain |
Suspension for use in drinking water |
5.5 log10EID50/dose |
Inactivated NDV strain NDV-SZ LaSota/ Inactivated IBV strain M-41/ Inactivated EDS strain B8-78 |
Emulsion for injection |
4 log HItitre , 6 log HItitre , 7 log HItitre |
Mycoplasma agalactiae strain N 262 inactivated |
Emulsion for injection |
=2mm |
Cl sordellii toxoid/Cl chauvoei anaculture/Cl perfringens Type A toxoid/Cl perfringens Type C toxoid/ Cl perfringens Type D toxoid/Cl septicum toxoid/Cl novyi Type B toxoid |
Suspension for injection |
2000i.u. , 7×10^8i.u. , 12i.u. , 33i.u. , 100i.u. , 7i.u. , 1000i.u. |
Staphylococcus aureus inactivated expressing Biofilm strain SP 140 |
Emulsion for injection |
8.98 log10ml |
Toxoid of Clostridium tetani/ Anaculture of Clostridium chauvoei/ B toxoid of Clostridium perfringens type B C and D/ E toxoid of Clostridium perfringens type B C and D/ a toxoid of Clostridium novyi type B/ a toxoid of Clostridium septicum |
Suspension for injection |
nlt 2.5ml , 100ml , nlt 10ml , nlt 5ml , nlt 3.5ml , nlt 2.5ml |
Mycoplasma agalactiae ovis inactivated strain 784 |
Suspension for injection |
1.5ml |
gE negative BHV1 strain GKD |
Lyophilisate and solvent for suspension for injection |
10^5.7TCID50 |
Inactivated Histophilus somni Bailie strain/ Mannheimia haemolytica Biotype A serotype A1 inactivated cell free suspension containing leukotoxoid |
Emulsion for injection |
3.3ml , 2.8ml |
Live Newcastle Disease Virus clone CL 79 |
Lyophilisate for suspension |
10^6.5EID50 |